help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHECHTER, M. S.
Right arrow Articles by FITZSIMMONS, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHECHTER, M. S.
Right arrow Articles by FITZSIMMONS, S. C.

Am. J. Respir. Crit. Care Med., Volume 163, Number 6, May 2001, 1331-1337

The Association of Socioeconomic Status with Outcomes in Cystic Fibrosis Patients in the United States

MICHAEL S. SCHECHTER, BRENT J. SHELTON, PETER A. MARGOLIS, and STACEY C. FITZSIMMONS

Departments of Pediatrics and Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem; Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina; and Cystic Fibrosis Foundation, Bethesda, Maryland

There is considerable variability in the clinical course of disease in cystic fibrosis (CF). Although currently unidentified modifier genes might explain some of this heterogeneity, other factors are probably contributory. Socioeconomic status (SES) is an important predictor of health status in many chronic polygenic diseases, but its role in CF has not been systematically evaluated. We performed a historical cohort analysis of pediatric CF patients in the United States using National Cystic Fibrosis Foundation Patient Registry (NCFPR) data for 1986 to 1994, and used Medicaid status as a proxy for low SES. The adjusted risk of death was 3.65 times higher (95% confidence interval [CI]: 3.03 to 4.40) for Medicaid patients than for those not receiving Medicaid. The percent predicted FEV1 of surviving Medicaid patients was less by 9.1% (95% CI: 6.9 to 11.2). Medicaid patients were 2.19 times more likely to be below the 5th percentile for weight (95% CI: 1.91 to 2.51) and 2.22 times more likely to be below the 5th percentile for height (95% CI: 1.95 to 2.52) than were non-Medicaid patients. Medicaid patients were 1.60 times more likely to require treatment for a pulmonary exacerbation (95% CI: 1.29 to 1.98). There was no difference in the number of outpatient clinic visits for Medicaid and non-Medicaid patients. We conclude that low SES is associated with significantly poorer outcomes in children with CF. Barriers in access to specialty health care do not seem to explain this difference. Further study is indicated to determine what adverse environmental factors might cluster in CF patients of low SES to cause worse outcomes.




This article has been cited by other articles:


Home page
 StrokeHome page
K. M. Rose, W. D. Rosamond, S. L. Huston, C. V. Murphy, and C. H. Tegeler
Predictors of Time From Hospital Arrival to Initial Brain-Imaging Among Suspected Stroke Patients: The North Carolina Collaborative Stroke Registry
Stroke, December 1, 2008; 39(12): 3262 - 3267.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
R. E. Foraker, K. M. Rose, A. P. McGinn, C. M. Suchindran, D. C. Goff Jr, E. A. Whitsel, J. L. Wood, and W. D. Rosamond
Neighborhood Income, Health Insurance, and Prehospital Delay for Myocardial Infarction: The Atherosclerosis Risk in Communities Study
Arch Intern Med, September 22, 2008; 168(17): 1874 - 1879.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. M. Collaco, L. Vanscoy, L. Bremer, K. McDougal, S. M. Blackman, A. Bowers, K. Naughton, J. Jennings, J. Ellen, and G. R. Cutting
Interactions Between Secondhand Smoke and Genes That Affect Cystic Fibrosis Lung Disease
JAMA, January 30, 2008; 299(4): 417 - 424.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. J. Hegewald and R. O. Crapo
Socioeconomic Status and Lung Function
Chest, November 1, 2007; 132(5): 1608 - 1614.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. L. Vanscoy, S. M. Blackman, J. M. Collaco, A. Bowers, T. Lai, K. Naughton, M. Algire, R. McWilliams, S. Beck, J. Hoover-Fong, et al.
Heritability of Lung Disease Severity in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., May 15, 2007; 175(10): 1036 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
C. H Goss and J. L Burns
Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis
Thorax, April 1, 2007; 62(4): 360 - 367.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. Padman, S. A. McColley, D. P. Miller, M. W. Konstan, W. J. Morgan, M. S. Schechter, C. L. Ren, J. S. Wagener, and for the Investigators and Coordinators of the Epid
Infant Care Patterns at Epidemiologic Study of Cystic Fibrosis Sites That Achieve Superior Childhood Lung Function
Pediatrics, March 1, 2007; 119(3): e531 - e537.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
M. P. Boyle
Strategies for Identifying Modifier Genes in Cystic Fibrosis
Proceedings of the ATS, January 1, 2007; 4(1): 52 - 57.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J K Block, K L Vandemheen, E Tullis, D Fergusson, S Doucette, D Haase, Y Berthiaume, N Brown, P Wilcox, P Bye, et al.
Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria
Thorax, November 1, 2006; 61(11): 969 - 974.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. L. Larson, K. Ahijevych, A. Gift, L. Hoffman, S. L. Janson, D. M. Lanuza, N. K. Leidy, P. Meek, J. Roberts, T. Weaver, et al.
American thoracic society statement on research priorities in respiratory nursing.
Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 471 - 478.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Bush
Update in pediatrics 2005.
Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 585 - 592.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. A. Belkin, N. R. Henig, L. G. Singer, C. Chaparro, R. C. Rubenstein, S. X. Xie, J. Y. Yee, R. M. Kotloff, D. A. Lipson, and G. R. Bunin
Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation
Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 659 - 666.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. B. Davis
Cystic Fibrosis Since 1938
Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 475 - 482.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
I. Nathanson, G. Ramirez-Garnica, and S. A. Wiltrout
Decreased Attendance at Cystic Fibrosis Centers by Children Covered by Managed Care Insurance
Am J Public Health, November 1, 2005; 95(11): 1958 - 1963.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. A. Flume, C. Strange, X. Ye, M. Ebeling, T. Hulsey, and L. L. Clark
Pneumothorax in Cystic Fibrosis
Chest, August 1, 2005; 128(2): 720 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Chronic Respiratory DiseaseHome page
N A Jarad, S Higgs, T Jeffcote, and K Giles
Factors associated with reduced FEV1 in adult patients with cystic fibrosis in a relatively affluent area
Chronic Respiratory Disease, July 1, 2005; 2(3): 133 - 137.
[Abstract] [PDF]

Home page
 ThoraxHome page
J de Gracia, F Mata, A Alvarez, T Casals, S Gatner, M Vendrell, D de la Rosa, L Guarner, and E Hermosilla
Genotype-phenotype correlation for pulmonary function in cystic fibrosis
Thorax, July 1, 2005; 60(7): 558 - 563.
[Abstract] [Full Text] [PDF]

Home page
 The Journal of School NursingHome page
M. T. Strawhacker and J. Wellendorf
Caring for Children With Cystic Fibrosis: A Collaborative Clinical and School Approach
The Journal of School Nursing, February 1, 2004; 20(1): 5 - 15.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
G. T. O'Connor, H. B. Quinton, T. Kneeland, R. Kahn, T. Lever, J. Maddock, P. Robichaud, M. Detzer, and D. R. Swartz
Median Household Income and Mortality Rate in Cystic Fibrosis
Pediatrics, April 1, 2003; 111(4): e333 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. N. Olivier, D. J. Weber, R. J. Wallace Jr., A. R. Faiz, J.-H. Lee, Y. Zhang, B. A. Brown-Elliot, A. Handler, R. W. Wilson, M. S. Schechter, et al.
Nontuberculous Mycobacteria: I: Multicenter Prevalence Study in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 828 - 834.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. D. Arkwright, V. Pravica, P. J. Geraghty, M. Super, A. K. Webb, M. Schwarz, and I. V. Hutchinson
End-Organ Dysfunction in Cystic Fibrosis: Association with Angiotensin I Converting Enzyme and Cytokine Gene Polymorphisms
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 384 - 389.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. D. Frangolias, C. L. Holloway, S. Vedal, and P. G. Wilcox
Role of Exercise and Lung Function in Predicting Work Status in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 150 - 157.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 619 - 630.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society 		  ATS Best of the Web